Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
ATRI

ATRI - Atrion Corp Stock Price, Fair Value and News

487.08USD-8.91 (-1.80%)Delayed as of 16 May 2024, 10:52 am ET

Market Summary

ATRI
USD487.08-8.91
Delayedas of 16 May 2024, 10:52 am
-1.80%

ATRI Stock Price

View Fullscreen

ATRI RSI Chart

ATRI Valuation

Market Cap

872.9M

Price/Earnings (Trailing)

46.64

Price/Sales (Trailing)

4.94

EV/EBITDA

-2.7K

Price/Free Cashflow

75.67

ATRI Price/Sales (Trailing)

ATRI Profitability

Operating Margin

51.78%

EBT Margin

-0.44%

Return on Equity

7.74%

Return on Assets

7.24%

Free Cashflow Yield

1.32%

ATRI Fundamentals

ATRI Revenue

Revenue (TTM)

176.7M

Rev. Growth (Yr)

18.36%

Rev. Growth (Qtr)

8.6%

ATRI Earnings

Earnings (TTM)

18.7M

Earnings Growth (Yr)

-19.89%

Earnings Growth (Qtr)

-56.54%

Breaking Down ATRI Revenue

52 Week Range

395.60602.59
(Low)(High)

Last 7 days

20.8%

Last 30 days

24.3%

Last 90 days

40.1%

Trailing 12 Months

-11.2%

How does ATRI drawdown profile look like?

ATRI Financial Health

Current Ratio

9.18

ATRI Investor Care

Dividend Yield

1.76%

Dividend/Share (TTM)

8.75

Buy Backs (1Y)

0.03%

Diluted EPS (TTM)

10.64

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024176.7M000
2023176.4M171.3M168.6M169.3M
2022173.0M179.2M180.9M183.5M
2021143.2M147.9M157.0M165.0M
2020157.0M154.9M149.8M147.6M
2019154.7M155.9M155.5M155.1M
2018147.5M150.2M151.5M152.4M
2017145.8M145.8M145.9M146.6M
2016143.6M142.1M142.6M143.5M
2015142.7M145.3M146.1M145.7M
2014134.9M137.3M139.9M140.8M
2013123.3M125.2M128.6M132.0M
2012116.4M115.9M116.1M119.1M
2011112.3M115.5M118.8M117.7M
20100103.3M105.9M108.6M
2009000100.6M

Tracking the Latest Insider Buys and Sells of Atrion Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 08, 2024
ferguson cindy
sold (taxes)
-19,836
440
-45.00
officer / cfo
Mar 08, 2024
ferguson cindy
acquired
-
-
163
officer / cfo
Dec 01, 2023
athey preston g
bought
95,904
319
300
-
Nov 16, 2023
battat david a
bought
90,000
300
300
president & ceo
Sep 20, 2023
bankes jeannette
acquired
82,589
444
186
-
Aug 15, 2023
athey preston g
acquired
104,670
523
200
-
Aug 15, 2023
athey preston g
bought
104,670
523
200
-
Jul 01, 2023
battat david a
acquired
-
-
310
president & ceo
Jul 01, 2023
battat emile a
acquired
-
-
310
director,chairman of the board
Jul 01, 2023
battat emile a
back to issuer
-175,870
565
-310
director,chairman of the board

1–10 of 50

Which funds bought or sold ATRI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 15, 2024
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
new
-
2,298,740
2,298,740
0.01%
May 15, 2024
Vestmark Advisory Solutions, Inc.
added
16.06
176,397
595,971
0.03%
May 15, 2024
T. Rowe Price Investment Management, Inc.
added
20.16
20,578,000
64,320,000
0.04%
May 15, 2024
BARCLAYS PLC
reduced
-39.26
-227,000
658,000
-%
May 15, 2024
TOWNSQUARE CAPITAL LLC
added
4.78
125,213
568,776
0.01%
May 15, 2024
Tower Research Capital LLC (TRC)
reduced
-93.7
-94,393
7,880
-%
May 15, 2024
Steward Partners Investment Advisory, LLC
reduced
-15.3
4,888
138,601
-%
May 15, 2024
JANUS HENDERSON GROUP PLC
added
0.16
51,993
294,236
-%
May 15, 2024
QUADRANT CAPITAL GROUP LLC
reduced
-58.95
-17,907
18,079
-%
May 15, 2024
Royal Bank of Canada
reduced
-3.31
143,000
922,000
-%

1–10 of 50

Are Funds Buying or Selling ATRI?

Are funds buying ATRI calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ATRI
No. of Funds

Unveiling Atrion Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
t. rowe price investment management, inc.
6.6%
115,477
SC 13G
Feb 13, 2024
kayne anderson rudnick investment management llc
11.07%
194,800
SC 13G/A
Feb 12, 2024
neuberger berman group llc
10.40%
183,012
SC 13G/A
Jan 29, 2024
blackrock inc.
6.6%
115,446
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
0.5%
8,777
SC 13G/A
Feb 14, 2023
t. rowe price investment management, inc.
6.5%
115,570
SC 13G
Feb 14, 2023
kayne anderson rudnick investment management llc
10.76%
190,681
SC 13G/A
Feb 10, 2023
neuberger berman group llc
10.99%
194,910
SC 13G/A
Feb 01, 2023
blackrock inc.
6.4%
113,355
SC 13G/A
Feb 14, 2022
kayne anderson rudnick investment management llc
10.58%
190,555
SC 13G/A

Recent SEC filings of Atrion Corp

View All Filings
Date Filed Form Type Document
May 10, 2024
8-K
Current Report
May 10, 2024
10-Q
Quarterly Report
Apr 09, 2024
DEFA14A
DEFA14A
Apr 09, 2024
DEF 14A
DEF 14A
Apr 09, 2024
ARS
ARS
Mar 20, 2024
PRE 14A
PRE 14A
Mar 11, 2024
4
Insider Trading
Feb 29, 2024
8-K
Current Report
Feb 29, 2024
10-K
Annual Report
Feb 14, 2024
SC 13G
Major Ownership Report

Peers (Alternatives to Atrion Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
181.9B
40.3B
-3.99% -4.43%
32.33
4.51
-2.84% -3.08%
68.5B
19.7B
1.04% -5.28%
51.42
3.48
4.82% -17.56%
21.1B
3.9B
-8.05% -4.13%
45.63
5.39
5.72% 46.72%
18.1B
14.9B
-11.51% -17.62%
6.82
1.21
2.98% 207.68%
MID-CAP
9.8B
3.5B
6.53% 24.43%
31.2
2.75
6.16% 35.06%
9.6B
12.5B
5.70% -3.02%
24.67
0.77
-0.61% -18.83%
8.6B
2.6B
0.13% -21.80%
-26.61
3.29
-6.25% -68.62%
5.9B
3.9B
-8.58% -30.13%
-62.71
1.49
0.23% 91.03%
3.5B
387.1M
0.52% 27.70%
-216.75
8.92
30.82% 65.57%
2.3B
6.6B
1.85% -3.48%
11.96
0.35
2.78% -0.87%
SMALL-CAP
1.3B
3.2B
-0.51% -11.36%
-1.88
0.4
7.94% -1661.78%
386.7M
169.3M
3.28% 2.59%
-5.03
2.28
7.49% -244.90%
254.7M
324.0M
0.79% -32.56%
-1.32
0.79
-3.19% -337.41%
48.8M
50.5M
2.90% -74.91%
-2.14
0.97
14.25% -10.06%
1.0M
3.7M
-72.41% 25.00%
-0.09
0.28
5.77% 8.23%

Atrion Corp News

Latest updates
Simply Wall St • 12 May 2024 • 02:38 pm
Defense World • 04 May 2024 • 07:35 am
Simply Wall St • 17 Apr 2024 • 07:00 am
Markets Insider • 4 months ago

Atrion Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue8.6%47,33443,58441,91143,83839,99342,85544,63148,88247,13840,29342,85542,69339,16932,24433,78537,96843,59434,46638,88340,10341,614
Cost Of Revenue-----------------23,72618,96420,99221,51122,911
Gross Profit126.8%12,351-46,00813,73617,25415,081-57,65417,65320,83319,244-51,92617,79017,86716,33913,92914,89817,46919,86815,50217,89118,59218,703
Operating Expenses130.6%9,209-30,1169,6709,87510,611-26,8118,0509,8048,994-23,7588,3128,0727,4087,6047,3157,4238,1547,4277,4417,6267,666
  S&GA Expenses137.6%2,772-7,3822,3482,3172,727-7,4412,3062,6292,517-5,8732,0811,8741,9261,8601,8881,7032,0702,2392,0922,0982,384
  R&D Expenses132.4%1,650-5,0991,8691,6071,630-4,1751,2511,5531,377-4,1411,3931,4451,3101,4811,3881,0921,6841,3601,3591,2241,095
EBITDA Margin-927.0%0.00*0.00*-0.09*-0.05*-0.03*0.00*0.02*0.01*0.01*0.00*-----------
Interest Expenses100.0%--12397.0027.00-----------------
Income Taxes117.2%411-2,396-5681,043514-3,864-1,7451,7251,673-8,2331,309-2,0161,55012,116-1,32114554.001,5481,4824,496-2,392
Earnings Before Taxes121.2%3,203-15,0893,5077,6063,999-31,78810,58411,07310,172-29,7649,58610,9419,2767,9588,56410,76711,17941,975-1,482-2,04411,830
EBT Margin-3417.4%0.00*0.00*-0.10*-0.06*-0.03*0.00*0.01*0.01*0.01*0.00*0.24*0.25*0.26*--------
Net Income-56.5%2,7926,4242,9396,5633,4858,3228,8399,3488,4998,1278,2778,9257,7267,3707,2438,6058,8988,0649,5959,6649,438
Net Income Margin-7.6%0.11*0.11*0.13*0.16*0.17*0.19*0.19*0.19*0.20*0.20*0.21*0.21*0.22*--------
Free Cashflow-21.5%8,32310,6072,363-9,757-3,215-3,630536-1,1804,270-17,206-23,988-28,161-29,381--------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-1.2%259262265267261267272275272267269268269267263260260262257249241
  Current Assets97938.6%1130.001161161150.00133138139137134126120112113102128132145133125
    Cash Equivalents200040.3%7.000.001.000.005.000.0027.0016.0025.000.0024.0017.0029.000.0024.0024.0044.0045.0064.0050.0044.00
  Inventory-8.9%75.0082.0083.0080.0075.0066.0060.0054.0051.0051.0047.0048.0050.0050.0049.0046.0041.0042.0038.0035.0033.00
  Net PPE99310.4%1250.001271281250.0011510910298.0097.0096.0095.0095.0091.0088.0085.0085.0082.0080.0076.00
  Goodwill99900.0%10.000.0010.0010.0010.000.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.00
Liabilities----------23.0024.0025.0026.0026.0026.0025.0025.0024.0023.0022.0021.00
  Current Liabilities96976.3%12.000.0015.0016.0017.000.0018.0019.0016.0013.0015.0013.0011.0014.0013.0015.0013.0011.0011.0011.0011.00
Shareholder's Equity99502.3%2420.002402412390.002462462460.002392412450.00238234235238232225218
  Retained Earnings99614.7%3810.003793803770.00373368362357353348342338334329324318313306299
  Additional Paid-In Capital100109.4%67.000.0067.0067.0066.000.0066.0066.0062.0061.0061.0060.0060.0054.0054.0053.0052.0052.0052.0051.0051.00
Accumulated Depreciation101978.2%1640.001571541500.00144141138135133129126124122120119116114111109
Shares Outstanding-0.1%2.002.002.002.002.002.002.002.002.002.002.002.00---------
Float----767---870---874---905---1,228-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations226.0%11,498-9,1275,418-5984,328-28,91810,6106,49011,847-28,78612,7978,6247,40410,4719,3266,59212,8316,30012,03311,22712,905
  Share Based Compensation117.8%235-1,317280632407-1,521202791530-1,763428841497191549613378376326600380
Cashflow From Investing-188.6%-4,0364,553-1,845-2,635-77.008,1849,184-5,105-12,2781523,800-7,3073,357-7,030-6,228-15,888-1,686-22,0504,913-2,585-25,114
Cashflow From Financing-145.0%-3,8928,647-3,224-1,021-4,41925,846-9,106-9,834-6,94727,438-10,011-13,674-3,784-4,987-3,201-10,685-12,113-2,875-2,875-3,083-2,501
  Dividend Payments100.0%--11,4243,8723,7843,784-10,8093,8373,4873,500-9,882-----14,6132,8382,86818,635-12,8852,5042,501
  Buy Backs100.0%--1,66517.001,037613-14,4045,0905,8933,447-16,9716,500-8,718-7,392-1,794--7,792-9,245----
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

ATRI Income Statement

2024-03-31
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)  
Revenues$ 47,334$ 39,993
Cost of goods sold34,98324,912
Gross profit12,35115,081
Operating expenses:  
Selling2,7722,727
General and administrative4,7876,254
Research and development1,6501,630
Operating expenses9,20910,611
Operating income3,1424,470
Interest and dividend income156240
Other investment income/(losses)(109)(721)
Other income1410
Total other income expense61(471)
Income before provision for income taxes3,2033,999
Provision for income taxes(411)(514)
Net income$ 2,792$ 3,485
Net income per basic share$ 1.59$ 1.98
Weighted average basic shares outstanding1,7601,762
Net income per diluted share$ 1.59$ 1.98
Weighted average diluted shares outstanding1,7611,763
Dividends per common share$ 2.20$ 2.15

ATRI Balance Sheet

2024-03-31
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 7,135$ 3,565
Short-term investments2,7602,691
Accounts receivable25,11623,029
Inventories75,00082,307
Prepaid expenses and other current assets2,5033,173
Total current assets112,514114,765
Long-term investments8,8538,165
Property, plant and equipment289,054286,445
Less accumulated depreciation and amortization164,446161,098
Property plant and equipment net124,608125,347
Other assets and deferred charges:  
Patents and licenses1,0431,072
Goodwill9,7309,730
Other1,8791,746
Total other assets and deferred charges12,65212,548
Total assets258,627260,825
Current liabilities:  
Accounts payable and accrued liabilities11,11212,515
Accrued income and other taxes1,140106
Total current liabilities12,25212,621
Other non-current liabilities4,4525,315
Stockholders' equity:  
Common stock, par value $0.10 per share; authorized 10,000 shares, issued 3,420 shares342342
Additional paid-in capital67,47267,331
Retained earnings380,665381,754
Treasury shares,1,660 at March 31, 2024 and 1,660 at December 31, 2023, at cost(206,556)(206,538)
Total stockholders' equity241,923242,889
Total liabilities and stockholders' equity$ 258,627$ 260,825
ATRI
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of specialized medical devices that include disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
 CEO
 WEBSITEatrioncorp.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES722

Atrion Corp Frequently Asked Questions


What is the ticker symbol for Atrion Corp? What does ATRI stand for in stocks?

ATRI is the stock ticker symbol of Atrion Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Atrion Corp (ATRI)?

As of Wed May 15 2024, market cap of Atrion Corp is 872.92 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ATRI stock?

You can check ATRI's fair value in chart for subscribers.

What is the fair value of ATRI stock?

You can check ATRI's fair value in chart for subscribers. The fair value of Atrion Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Atrion Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ATRI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Atrion Corp a good stock to buy?

The fair value guage provides a quick view whether ATRI is over valued or under valued. Whether Atrion Corp is cheap or expensive depends on the assumptions which impact Atrion Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ATRI.

What is Atrion Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed May 15 2024, ATRI's PE ratio (Price to Earnings) is 46.64 and Price to Sales (PS) ratio is 4.94. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ATRI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Atrion Corp's stock?

In the past 10 years, Atrion Corp has provided 0.056 (multiply by 100 for percentage) rate of return.